OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Organization: Athira Pharma Inc.

2 Projects | 2 Researchers | $1,572,623 Invested

2016

Athira Pharma Inc.

Leen Kawas, PhD

Phase I clinical trials of a novel neurotrophic activator drug to treat Alzheimer's disease

  • Funding Amount: $1,397,630
  • Organization Type: Biotechnology/For Profit
  • Program: Clinical
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed

2012

Athira Pharma Inc.

Joseph Harding, PhD

Development of small molecule hepatoctye growth factor mimetic for the treatment of dementia.

  • Funding Amount: $174,993
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Status: Closed